|4Feb 10, 4:04 PM ET

Kunkel Jay K. 4

Research Summary

AI-generated summary

Updated

Varex (VREX) Director Jay K. Kunkel Receives 8,483 Shares

What Happened
Jay K. Kunkel, a director of Varex Imaging Corp (VREX), received 8,483 shares on February 9, 2026 through the conversion/exercise of a derivative (reported with transaction code M). The filing shows the conversion/delivery of 8,483 Deferred Stock Units into common stock on a one-for-one basis; the reported price is $0.00, indicating no cash payment by the insider and no open‑market sale.

Key Details

  • Transaction date: February 9, 2026 (Form 4 filed February 10, 2026).
  • Reported transaction type/code: Exercise or conversion of derivative (M).
  • Shares involved: 8,483 shares converted/issued; reported as acquired via conversion and also reported as disposed at $0.00 (reflecting the derivative conversion mechanics, not a market sale).
  • Price/consideration: $0.00 shown for the disposition entry; no cash proceeds to the insider.
  • Footnotes: DSUs convert one-for-one into common stock. These DSUs were granted on Feb 9, 2023, vested Feb 8, 2024, and delivery of the vested units as common stock occurred on Feb 9, 2026 (third anniversary of the grant).
  • Shares owned after the transaction: Not provided in the supplied data.
  • Filing timeliness: Filed one day after the transaction (Feb 10, 2026), which is within the typical two-business-day Form 4 reporting window.

Context
This was not an open‑market purchase or sale but the conversion/delivery of previously granted deferred stock units as equity compensation. Such conversions are routine compensation events and do not necessarily signal a buying or selling intent in the market. The M code here reflects conversion/exercise of a derivative security rather than a cash exercise or immediate sale.